{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:58Z","timestamp":1786997938958,"version":"build-2736575974"},"reference-count":80,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["valuehealthregionalissues.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health Regional Issues"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.vhri.2025.101159","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:26:43Z","timestamp":1753273603000},"page":"101159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Predicting the EQ-5D-5L Utility Scores From the Impact of Vision Impairment Questionnaire in Thai Patients"],"prefix":"10.1016","volume":"50","author":[{"given":"Emilia A.T.","family":"Pasenggong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phantipa","family":"Sakthong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pear F.","family":"Pongsachareonnont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaew","family":"Tantirattanakulchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10159","key":"10.1016\/j.vhri.2025.101159_bib1","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0140-6736(18)32279-7","volume":"392","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vhri.2025.101159_bib2","first-page":"e130","article-title":"Vision Loss Expert Group of the Global Burden of Disease Study. Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study","volume":"9","year":"2021","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib3","doi-asserted-by":"crossref","DOI":"10.9745\/GHSP-D-22-00091","article-title":"Does the current global health agenda lack vision?","volume":"11","author":"Forrest","year":"2023","journal-title":"Glob Health Sci Pract"},{"issue":"12","key":"10.1016\/j.vhri.2025.101159_bib4","doi-asserted-by":"crossref","first-page":"e1221","DOI":"10.1016\/S2214-109X(17)30393-5","article-title":"Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis","volume":"5","author":"Flaxman","year":"2017","journal-title":"Lancet Glob Health"},{"issue":"5","key":"10.1016\/j.vhri.2025.101159_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bjophthalmol-2017-311258","article-title":"Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections","volume":"102","author":"Bourne","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.vhri.2025.101159_bib6","article-title":"The Finnish register of visual impairment","author":"Ojamo","year":"2018","journal-title":"Annual Statistics"},{"issue":"4","key":"10.1016\/j.vhri.2025.101159_bib7","doi-asserted-by":"crossref","first-page":"e489","DOI":"10.1016\/S2214-109X(20)30488-5","article-title":"The Lancet Global Health Commission on Global Eye Health: vision beyond 2020","volume":"9","author":"Burton","year":"2021","journal-title":"Lancet Glob Health"},{"issue":"12","key":"10.1016\/j.vhri.2025.101159_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0050244","article-title":"A case-control study to assess the relationship between poverty and visual impairment from cataract in Kenya, the Philippines, and Bangladesh","volume":"5","author":"Kuper","year":"2008","journal-title":"PLoS Med"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1080\/09286580601139212","article-title":"Impact of visual impairment on quality of life: a comparison with quality of life in the general population and with other chronic conditions","volume":"14","author":"Langelaan","year":"2007","journal-title":"Ophthal Epidemiol"},{"issue":"6","key":"10.1016\/j.vhri.2025.101159_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1159\/000316688","article-title":"Impact of low vision on employment","volume":"224","author":"Mojon-Azzi","year":"2010","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.vhri.2025.101159_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100852","article-title":"Global economic productivity losses from vision impairment and blindness","volume":"35","author":"Marques","year":"2021","journal-title":"EClinicalmedicine"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ophtha.2007.04.016","article-title":"Eye-related medicare costs for patients with age-related macular degeneration from 1995 to 1999","volume":"115","author":"Coleman","year":"2008","journal-title":"Ophthalmology"},{"issue":"1_suppl","key":"10.1016\/j.vhri.2025.101159_bib13","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1177\/0145482X0610001S07","article-title":"Double jeopardy: the effects of comorbid conditions among older people with vision loss","volume":"100","author":"Crews","year":"2006","journal-title":"J Vis Impairment Blindness"},{"issue":"8","key":"10.1016\/j.vhri.2025.101159_bib14","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s11136-021-02817-1","article-title":"Prevalence and 11-year incidence of common eye diseases and their relation to health-related quality of life, mental health, and visual impairment","volume":"30","author":"Purola","year":"2021","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.vhri.2025.101159_bib15","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/aos.15676","article-title":"Impact of vision on generic health-related quality of life-a systematic review","volume":"101","author":"Purola","year":"2023","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.vhri.2025.101159_bib16","doi-asserted-by":"crossref","first-page":"Np194","DOI":"10.1177\/1010539511433049","article-title":"Association between vision impairment and health among a national cohort of 87,134 Thai adults","volume":"27","author":"Yiengprugsawan","year":"2015","journal-title":"Asia Pac J Public Health"},{"key":"10.1016\/j.vhri.2025.101159_bib19","first-page":"607","article-title":"Quality of vision and attitude of the Thai elderly toward their eye problems","volume":"10","author":"Jenchitr","year":"2001","journal-title":"J Health Sci [in Thai]"},{"issue":"2","key":"10.1016\/j.vhri.2025.101159_bib20","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10198-009-0168-z","article-title":"A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures","volume":"11","author":"Brazier","year":"2010","journal-title":"Eur J Health Econ"},{"issue":"2","key":"10.1016\/j.vhri.2025.101159_bib21","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s40258-015-0219-9","article-title":"A systematic review of the literature on the development of condition-specific preference-based measures of health","volume":"14","author":"Goodwin","year":"2016","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.vhri.2025.101159_bib22","first-page":"61","article-title":"Patient-reported outcomes (PROs) and patient-reported outcome measures (PROMs)","volume":"6","author":"Weldring","year":"2013","journal-title":"Health Serv Insights"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hec.3564","article-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England","volume":"27","author":"Devlin","year":"2018","journal-title":"Health Econ"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","article-title":"A time trade-off-derived value set of the EQ-5D-5L for Canada","volume":"54","author":"Xie","year":"2016","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.vhri.2025.101159_bib25","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jval.2016.03.1834","article-title":"Comparison of Value Set Based on DCE and\/or TTO Data: scoring for EQ-5D-5L Health States in Japan","volume":"19","author":"Shiroiwa","year":"2016","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101159_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D","volume":"19","author":"Matthijs","year":"2016","journal-title":"Value Health"},{"issue":"6","key":"10.1016\/j.vhri.2025.101159_bib27","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11136-011-0018-1","article-title":"Comparing the psychometric properties of the EQ-5D-3L and EQ-5D-5L in cancer patients in Korea","volume":"21","author":"Kim","year":"2012","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.vhri.2025.101159_bib28","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/14737167.2018.1494574","article-title":"The EQ-5D-5L Valuation study in Thailand","volume":"18","author":"Pattanaphesaj","year":"2018","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"5","key":"10.1016\/j.vhri.2025.101159_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155509","article-title":"The impact of vision impairment (IVI) questionnaire; validation of the Thai-version and the implementation on vision-related quality of life in Thai rural community","volume":"11","author":"Ratanasukon","year":"2016","journal-title":"PLOS One"},{"issue":"5","key":"10.1016\/j.vhri.2025.101159_bib30","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s40258-015-0191-4","article-title":"Preferred reporting items for studies mapping onto preference-based outcome measures: the MAPS statement","volume":"13","author":"Petrou","year":"2015","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.vhri.2025.101159_bib31","author":"Longworth"},{"issue":"9","key":"10.1016\/j.vhri.2025.101159_bib32","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s10198-020-01220-w","article-title":"Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas","volume":"21","author":"Xu","year":"2020","journal-title":"Eur J Health Econ"},{"issue":"4","key":"10.1016\/j.vhri.2025.101159_bib33","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.31557\/APJCP.2023.24.4.1125","article-title":"Mapping EORTC-QLQ-C30 onto EQ-5D-5L index in Indonesian cancer patients","volume":"24","author":"Perwitasari","year":"2023","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"10.1016\/j.vhri.2025.101159_bib34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11136-023-03540-9","article-title":"Mapping the EORTC QLQ-C30 and QLQ H&N35 to the EQ-5D-5L and SF-6D for papillary thyroid carcinoma","volume":"33","author":"Huang","year":"2024","journal-title":"Qual Life Res"},{"issue":"5","key":"10.1016\/j.vhri.2025.101159_bib35","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2022-0178","article-title":"Mapping the EORTC QLQ-C30 onto the EQ-5D-5L index for patients with paroxysmal nocturnal hemoglobinuria in France","volume":"12","author":"Wojciechowski","year":"2023","journal-title":"J Comp Eff Res"},{"issue":"9","key":"10.1016\/j.vhri.2025.101159_bib36","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s11136-020-02499-1","article-title":"Mapping Dermatology Life Quality Index (DLQI) scores to EQ-5D utility scores using data of patients with atopic dermatitis from the National Health and Wellness Study","volume":"29","author":"Vilsb\u00f8ll","year":"2020","journal-title":"Qual Life Res"},{"issue":"11","key":"10.1016\/j.vhri.2025.101159_bib37","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1007\/s11136-017-1607-4","article-title":"Mapping of the DLQI scores to EQ-5D utility values using ordinal logistic regression","volume":"26","author":"Ali","year":"2017","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s12955-020-01368-2","article-title":"Mapping the Minnesota living with heart failure questionnaire (MLHFQ) to EQ-5D-5L in patients with heart failure","volume":"18","author":"Kularatna","year":"2020","journal-title":"Health Qual Life Outcomes"},{"issue":"12","key":"10.1016\/j.vhri.2025.101159_bib39","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.jval.2024.07.016","article-title":"Direct and indirect mapping of assessment of quality of life-6 dimensions (AQoL-6D), cross-sectional study of Malaysians with chronic heart failure","volume":"27","author":"Tan","year":"2024","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.vhri.2025.101159_bib40","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/ehjqcco\/qcab014","article-title":"Predicting the EQ-5D utilities from the Kansas City cardiomyopathy Questionnaire in patients with heart failure","volume":"7","author":"Thomas","year":"2021","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"9","key":"10.1016\/j.vhri.2025.101159_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18090","article-title":"Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modeling and survey","volume":"18","author":"Longworth","year":"2014","journal-title":"Health Technol Assess"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib42","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jval.2011.08.002","article-title":"A review of generic preference-based measures of health-related quality of life in visual disorders","volume":"15","author":"Tosh","year":"2012","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.vhri.2025.101159_bib43","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/OPX.0000000000000005","article-title":"Responsiveness of the EQ-5D to the effects of low vision rehabilitation","volume":"90","author":"Malkin","year":"2013","journal-title":"Optom Vis Sci"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib44","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1080\/09286586.2016.1257027","article-title":"Multivariable regression model of the EuroQol 5-dimension questionnaire in patients seeking outpatient low vision rehabilitation","volume":"24","author":"Malkin","year":"2017","journal-title":"Ophthal Epidemiol"},{"issue":"8","key":"10.1016\/j.vhri.2025.101159_bib45","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1080\/08820538.2021.1896750","article-title":"Quality of life among patients with retinal vein occlusion: a case-control study","volume":"36","author":"Chatzirallis","year":"2021","journal-title":"Semin Ophthalmol"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib46","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jval.2011.11.031","article-title":"QALY weights for diabetic retinopathy--a comparison of health state valuations with HUI-3, EQ-5D, EQ-VAS, and TTO","volume":"15","author":"Heintz","year":"2012","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2025.101159_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2415-12-43","article-title":"A comparison of the sensitivity of EQ-5D, SF-6D and TTO utility values to changes in vision and perceived visual function in patients with primary open-angle glaucoma","volume":"12","author":"Bozzani","year":"2012","journal-title":"BMC Ophthalmol"},{"issue":"11","key":"10.1016\/j.vhri.2025.101159_bib48","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1167\/iovs.06-0220","article-title":"The impact of vision impairment questionnaire: an evaluation of its measurement properties using Rasch analysis","volume":"47","author":"Lamoureux","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1167\/iovs.06-0361","article-title":"The impact of vision impairment questionnaire: an assessment of its domain structure using confirmatory factor analysis and rasch analysis","volume":"48","author":"Lamoureux","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.vhri.2025.101159_bib50","series-title":"Value Sets for EQ-5D-5L: A Compendium, Comparative Review & User Guide","first-page":"1","article-title":"The development of the EQ-5D-5L and its value sets","author":"Devlin","year":"2022"},{"issue":"4","key":"10.1016\/j.vhri.2025.101159_bib51","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.3390\/ijerph17041423","article-title":"Hybrid methodology to improve health status utility values derivation using EQ-5D-5L and advanced multi-criteria techniques","volume":"17","author":"V\u00e1squez","year":"2020","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0168-8510(96)00822-6","article-title":"EuroQol: the current state of play","volume":"37","author":"Brooks","year":"1996","journal-title":"Health Policy"},{"key":"10.1016\/j.vhri.2025.101159_bib53","series-title":"The Guideline of Health Technology Assessment in Thailand","article-title":"Health utility","author":"Tavorncharoensup","year":"2025"},{"issue":"12","key":"10.1016\/j.vhri.2025.101159_bib54","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1007\/s11136-015-1038-z","article-title":"Psychometric properties of the EQ-5D-5L in Thai patients with chronic diseases","volume":"24","author":"Sakthong","year":"2015","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.vhri.2025.101159_bib55","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11136-009-9499-6","article-title":"Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration","volume":"18","author":"Payakachat","year":"2009","journal-title":"Qual Life Res"},{"issue":"4","key":"10.1016\/j.vhri.2025.101159_bib56","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1524-4733.2010.00695.x","article-title":"Analysis of health utility data when some subjects attain the upper bound of 1: are Tobit and CLAD models appropriate?","volume":"13","author":"Pullenayegum","year":"2010","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib57","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jval.2011.12.014","article-title":"Tails from the peak district: adjusted limited dependent variable mixture models of EQ-5D questionnaire health state utility values","volume":"15","author":"Hern\u00e1ndez Alava","year":"2012","journal-title":"Value Health"},{"issue":"12","key":"10.1016\/j.vhri.2025.101159_bib58","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.jval.2018.06.006","article-title":"Mapping the FACT-B Instrument to EQ-5D-3L in Patients with Breast Cancer Using Adjusted Limited Dependent Variable Mixture Models versus Response Mapping","volume":"21","author":"Gray","year":"2018","journal-title":"Value Health"},{"issue":"8","key":"10.1016\/j.vhri.2025.101159_bib59","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s10198-019-01088-5","article-title":"Mapping the kidney disease quality of life 36-item short form survey (KDQOL-36) to the EQ-5D-3L and the EQ-5D-5L in patients undergoing dialysis","volume":"20","author":"Yang","year":"2019","journal-title":"Eur J Health Econ"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1080\/00273171.2015.1095063","article-title":"Regression mixture models: does modeling the covariance between independent variables and latent classes improve the results?","volume":"51","author":"Lamont","year":"2016","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.vhri.2025.101159_bib61","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1177\/1536867X1501500307","article-title":"Fitting adjusted limited dependent variable mixture models to EQ-5D","volume":"15","author":"Hern\u00e1ndez Alava","year":"2015","journal-title":"STATA J"},{"key":"10.1016\/j.vhri.2025.101159_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/bmb\/ldr049","article-title":"Mapping for economic evaluation","volume":"101","author":"Chuang","year":"2012","journal-title":"Br Med Bull"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib63","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s40258-019-00467-6","article-title":"An updated systematic review of studies mapping (or cross-walking) measures of health-related quality of life to generic preference-based measures to generate utility values","volume":"17","author":"Mukuria","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib64","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s11136-023-03567-y","article-title":"Development of algorithms to estimate the EQ-5D-5L from the FACT-L in patients with lung cancer: a mapping study","volume":"33","author":"Jiang","year":"2024","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jval.2012.10.010","article-title":"Mapping to obtain EQ-5D utility values for use in NICE health technology assessments","volume":"16","author":"Longworth","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/j.vhri.2025.101159_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1123552","article-title":"Mapping health assessment questionnaire disability index onto EQ-5D-5L in China","volume":"11","author":"Wan","year":"2023","journal-title":"Front Public Health"},{"issue":"11","key":"10.1016\/j.vhri.2025.101159_bib67","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1007\/s11136-018-1925-1","article-title":"Mapping between HAQ-DI and EQ-5D-5L in a Chinese patient population","volume":"27","author":"Patton","year":"2018","journal-title":"Qual Life Res"},{"issue":"7","key":"10.1016\/j.vhri.2025.101159_bib68","doi-asserted-by":"crossref","DOI":"10.1115\/1.4027161","article-title":"A robust error-pursuing sequential sampling approach for global metamodeling based on Voronoi diagram and cross validation","volume":"136","author":"Xu","year":"2014","journal-title":"J Mech Des"},{"issue":"8476","key":"10.1016\/j.vhri.2025.101159_bib69","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(86)90837-8","article-title":"Statistical methods for assessing agreement between two methods of clinical measurement","volume":"1","author":"Bland","year":"1986","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.vhri.2025.101159_bib70","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1007\/s11136-023-03420-2","article-title":"Normative profile of the EQ-5D-5L dimensions, EQ-5D-5L index and EQ-VAS scores for the general Thai population","volume":"32","author":"Kangwanrattanakul","year":"2023","journal-title":"Qual Life Res"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib71","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1111\/aos.14883","article-title":"Improving health-related quality of life in glaucoma during 11 years and its association with vision loss and treatment of the disease","volume":"100","author":"Purola","year":"2022","journal-title":"Acta Ophthalmol"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib72","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1093\/geronb\/gbr015","article-title":"Visual impairment and quality of life among older adults: an examination of explanations for the relationship","volume":"66","author":"Brown","year":"2011","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"issue":"8","key":"10.1016\/j.vhri.2025.101159_bib73","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s11136-011-0061-y","article-title":"The impact of low vision on activities of daily living, symptoms of depression, feelings of anxiety and social support in community-living older adults seeking vision rehabilitation services","volume":"21","author":"Kempen","year":"2012","journal-title":"Qual Life Res"},{"issue":"19","key":"10.1016\/j.vhri.2025.101159_bib74","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003523","article-title":"Mental health status and quality of life in undiagnosed glaucoma patients: a nationwide population-based study","volume":"95","author":"Jung","year":"2016","journal-title":"Med (Baltim)"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib75","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1038\/s41598-022-12425-9","article-title":"Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains","volume":"12","author":"Gupta","year":"2022","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.vhri.2025.101159_bib76","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ophtha.2020.07.046","article-title":"The differential impact of age on vision-related quality of life across the visual impairment spectrum","volume":"128","author":"Man","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vhri.2025.101159_bib77","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1477-7525-7-27","article-title":"Mapping SF-36 onto the EQ-5D index: how reliable is the relationship?","volume":"7","author":"Rowen","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"10","key":"10.1016\/j.vhri.2025.101159_bib78","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/eye.2012.137","article-title":"Estimating quality-adjusted life years from patient-reported visual functioning","volume":"26","author":"Browne","year":"2012","journal-title":"Eye (Lond)"},{"issue":"7","key":"10.1016\/j.vhri.2025.101159_bib79","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jval.2020.03.008","article-title":"Mapping from visual acuity to EQ-5D, EQ-5D with vision Bolt-On, and VFQ-UI in patients with macular edema in the LEAVO trial","volume":"23","author":"Pennington","year":"2020","journal-title":"Value Health"},{"issue":"15","key":"10.1016\/j.vhri.2025.101159_bib80","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.3390\/healthcare11152131","article-title":"Perspectives on aging and quality of life","volume":"11","author":"Noto","year":"2023","journal-title":"Healthcare (Basel)"},{"issue":"1","key":"10.1016\/j.vhri.2025.101159_bib81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jval.2016.11.006","article-title":"Mapping to estimate health-state utility from non-preference-based outcome measures: an ISPOR good practices for outcomes research task force report","volume":"20","author":"Wailoo","year":"2017","journal-title":"Value Health"},{"issue":"5","key":"10.1016\/j.vhri.2025.101159_bib82","doi-asserted-by":"crossref","first-page":"e736","DOI":"10.1111\/aos.16634","article-title":"EQ-5D-5L health utility scores in Australian adults with inherited retinal diseases: a cross-sectional survey","volume":"102","author":"McGuinness","year":"2024","journal-title":"Acta Ophthalmol"}],"container-title":["Value in Health Regional Issues"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000846?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212109925000846?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T08:47:27Z","timestamp":1762332447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212109925000846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":80,"alternative-id":["S2212109925000846"],"URL":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101159","relation":{},"ISSN":["2212-1099"],"issn-type":[{"value":"2212-1099","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting the EQ-5D-5L Utility Scores From the Impact of Vision Impairment Questionnaire in Thai Patients","name":"articletitle","label":"Article Title"},{"value":"Value in Health Regional Issues","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vhri.2025.101159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of International Society for Pharmacoeconomics and Outcomes Research, Inc.","name":"copyright","label":"Copyright"}],"article-number":"101159"}}